Similar articles

• Cartilage destruction in collagen induced arthritis assessed with a new biochemical marker for collagen type II C-telopeptide fragments.

  Ishikawa T, Nishigaki F, Christgau S, Noto T, Mo J, From N, Minoura K, Hirayama Y, Ohkubo Y, Mutoh S. Ishikawa T, et al. J Rheumatol. 2004 Jun;31(6):1174-9. J Rheumatol. 2004. PMID: 15170932
• Turnover of type II collagen and aggrecan in cartilage matrix at the onset of inflammatory arthritis in humans: relationship to mediators of systemic and local inflammation.

  Fraser A, Fearon U, Billinghurst RC, Ionescu M, Reece R, Barwick T, Emery P, Poole AR, Veale DJ. Fraser A, et al. Arthritis Rheum. 2003 Nov;48(11):3085-95. doi: 10.1002/art.11331. Arthritis Rheum. 2003. PMID: 14613270
• Anatomical localization of cartilage degradation markers in a surgically induced rat osteoarthritis model.

  Wancket LM, Baragi V, Bove S, Kilgore K, Korytko PJ, Guzman RE. Wancket LM, et al. Toxicol Pathol. 2005;33(4):484-9. doi: 10.1080/01926230590965364. Toxicol Pathol. 2005. PMID: 16036866
• [Matrix metalloproteinases and cartilage matrix degradation in rheumatoid arthritis].

  Yoshihara Y, Yamada H. Yoshihara Y, et al. Clin Calcium. 2007 Apr;17(4):500-8. Clin Calcium. 2007. PMID: 17404478 Review. Japanese.
• [Biochemical studies of potentially antiarthritic drugs].

  Greiling H. Greiling H. Z Rheumatol. 1983 Jul-Aug;42(4):153-8. Z Rheumatol. 1983. PMID: 6228079 Review. German. No abstract available.